Drug Approval | December 17, 2023
Zydus receives final USFDA approval for Cyclophosphamide Capsules USP, 25 mg and 50 mg
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cell
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cell
Expands patient reach to remotest towns by furthering investment in GoApptiv
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
his marks the 12th formulation facility under Akums, and the second in Baddi, a strategic move with an aim to enhance Akums’ manufacturing capabilities.
Ivabradine Tablets, 5 mg and 7.5 mg had annual sales of USD 136.5 mn in the United States
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
Multi-ethnic innovation helps all complexions appear clearer and more uniform
These regulatory approvals signify a significant milestone for Venus Remedies Limited
The product is expected to be launched in FY25
Subscribe To Our Newsletter & Stay Updated
